Columbus Macro LLC increased its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 11.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 185,100 shares of the real estate investment trust's stock after buying an additional 18,274 shares during the quarter. Columbus Macro LLC owned about 0.06% of Omega Healthcare Investors worth $6,784,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently added to or reduced their stakes in OHI. NBC Securities Inc. purchased a new position in Omega Healthcare Investors during the first quarter worth about $29,000. MassMutual Private Wealth & Trust FSB lifted its position in Omega Healthcare Investors by 562.3% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust's stock worth $67,000 after buying an additional 1,552 shares during the period. Register Financial Advisors LLC purchased a new position in Omega Healthcare Investors during the second quarter worth about $73,000. UMB Bank n.a. increased its stake in Omega Healthcare Investors by 94.9% during the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock worth $83,000 after acquiring an additional 1,059 shares during the last quarter. Finally, Trust Co. of Vermont acquired a new stake in Omega Healthcare Investors during the second quarter worth about $95,000. 65.25% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director owned 18,654 shares in the company, valued at $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.50% of the stock is currently owned by company insiders.
Omega Healthcare Investors Price Performance
OHI stock opened at $40.67 on Thursday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 7.10 and a current ratio of 7.10. Omega Healthcare Investors, Inc. has a 1 year low of $35.04 and a 1 year high of $44.42. The firm has a market cap of $12.00 billion, a P/E ratio of 25.10, a price-to-earnings-growth ratio of 1.91 and a beta of 0.70. The stock has a 50-day simple moving average of $41.55 and a 200-day simple moving average of $38.77.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The firm had revenue of $235.60 million during the quarter, compared to analyst estimates of $248.49 million. During the same quarter last year, the firm earned $0.71 EPS. Omega Healthcare Investors's quarterly revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, equities analysts predict that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.
Omega Healthcare Investors Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 6.6%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is 165.43%.
Analysts Set New Price Targets
Several equities research analysts have commented on the company. Mizuho upped their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a research note on Thursday, September 11th. Scotiabank upped their price target on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 28th. Wells Fargo & Company upped their price target on Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 27th. Royal Bank Of Canada upped their price target on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 7th. Finally, Truist Financial upped their price target on Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a "hold" rating in a research note on Wednesday, September 3rd. Seven investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $44.44.
View Our Latest Analysis on OHI
Omega Healthcare Investors Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.